University of Tennessee Erlanger Oncology & Hematology — Chattanooga, Tennessee

University of Tennessee Erlanger Oncology & Hematology is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Tennessee Erlanger Oncology & Hematology has participated in 2 clinical trials.

Therapeutic areas: Renal Cell Carcinoma (RCC), Carcinoma, Non-Small-Cell Lung.

Sponsors: Incyte Corporation, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Erlanger Oncology & Hematology?

University of Tennessee Erlanger Oncology & Hematology has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Erlanger Oncology & Hematology conducted?

University of Tennessee Erlanger Oncology & Hematology has 2 clinical trials on record. Their work covers Renal Cell Carcinoma (RCC), Carcinoma, Non-Small-Cell Lung.

Is University of Tennessee Erlanger Oncology & Hematology accredited by Crixeo Clinical Trials?

University of Tennessee Erlanger Oncology & Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Erlanger Oncology & Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.